|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim YK, Lee GS, Jung EM, Hyun SH, Hwang WS
and Jeung EB: Generation of fibroblasts overexpressing
liver-specific PEPCK in a miniature pig model of human type 2
diabetes mellitus. Mol Med Rep. 6:45–50. 2012.PubMed/NCBI
|
|
3
|
Rampone B, Schiavone B, Martino A, Viviano
C and Confuorto G: Current management strategy of hepatocellular
carcinoma. World J Gastroenterol. 15:3210–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y and
Miao Y: Meta-analysis of surgical resection and radiofrequency
ablation for early hepatocellular carcinoma. World J Surg Oncol.
10:16320122012. View Article : Google Scholar
|
|
5
|
Salhab M and Canelo R: An overview of
evidence-based management of hepatocellular carcinoma: a
meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar
|
|
6
|
Zhou XD: Recurrence and metastasis of
hepatocellular carcinoma: progress and prospects. Hepatobiliary
Pancreat Dis Int. 1:35–41. 2002.
|
|
7
|
Guan M, Zhou X, Soulitzis N, Spandidos DA
and Popescu NC: Aberrant methylation and deacetylation of deleted
in liver cancer-1 gene in prostate cancer: potential clinical
applications. Clin Cancer Res. 12:1412–1419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lizarraga IM, Sugg SL, Weigel RJ and
Scott-Conner CE: Review of risk factors for the development of
contralateral breast cancer. Am J Surg. 206:704–708. 2013.
View Article : Google Scholar
|
|
9
|
Chapuis N, Tamburini J, Cornillet-Lefebvre
P, Gillot L, Bardet V, Willems L, Park S, Green AS, Ifrah N,
Dreyfus F, et al: Autocrine IGF-1/IGF-1R signaling is responsible
for constitutive PI3K/Akt activation in acute myeloid leukemia:
therapeutic value of neutralizing anti-IGF-1R antibody.
Haematologica. 95:415–423. 2010. View Article : Google Scholar :
|
|
10
|
Muders MH, Zhang H, Wang E, Tindall DJ and
Datta K: Vascular endothelial growth factor-C protects prostate
cancer cells from oxidative stress by the activation of mammalian
target of rapamycin complex-2 and AKT-1. Cancer Res. 69:6042–6048.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Opel D, Poremba C, Simon T, Debatin KM and
Fulda S: Activation of Akt predicts poor outcome in neuroblastoma.
Cancer Res. 67:735–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chagpar RB, Links PH, Pastor MC, Furber
LA, Hawrysh AD, Chamberlain MD and Anderson DH: Direct positive
regulation of PTEN by the p85 subunit of phosphatidylinositol
3-kinase. Proc Natl Acad Sci USA. 107:5471–5476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lopez-Carballo G, Moreno L, Masia S, Perez
P and Barettino D: Activation of the phosphatidylinositol
3-kinase/Akt signaling pathway by retinoic acid is required for
neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol
Chem. 277:25297–25304. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang XW, Wang XL, Cao LQ, Jiang XF, Peng
HP, Lin SM, Xue P and Chen D: Green tea polyphenol
epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell
growth inhibition of hepatocellular carcinoma cells. Hepatol Res.
42:494–501. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugiyama M, Sakahara H, Torizuka T, Kanno
T, Nakamura F, Futatsubashi M and Nakamura S: 18F-FDG
PET in the detection of extrahepatic metastases from hepatocellular
carcinoma. J Gastroenterol. 39:961–968. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Park JY, Kim do Y, Ahn SH, Han KH,
Seo HJ, Lee JD and Choi HJ: Prognostic value of 18F-FDG
PET for hepatocellular carcinoma patients treated with sorafenib.
Liver Int. 31:1144–1149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paudyal B, Oriuchi N, Paudyal P, Tsushima
Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T and Endo K:
Clinicopathological presentation of varying 18F-FDG
uptake and expression of glucose transporter 1 and hexokinase II in
cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Ann Nucl Med. 22:83–86. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng KK, Poon RT, Lo CM, Yuen J, Tso WK and
Fan ST: Analysis of recurrence pattern and its influence on
survival outcome after radiofrequency ablation of hepatocellular
carcinoma. J Gastrointest Surg. 12:183–191. 2008. View Article : Google Scholar
|
|
19
|
Berg M and Soreide K: EGFR and downstream
genetic alterations in KRAS/BRAF and PI3K/AKT pathways in
colorectal cancer: implications for targeted therapy. Discov Med.
14:207–214. 2012.PubMed/NCBI
|
|
20
|
Radisavljevic Z: AKT as locus of cancer
angiogenic robustness and fragility. J Cell Physiol. 228:21–24.
2013. View Article : Google Scholar
|
|
21
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Balogova L, Maslanakova M, Dzurova L,
Miskovsky P and Stroffekova K: Bcl-2 proapoptotic proteins
distribution in U-87 MG glioma cells before and after hypericin
photodynamic action. Gen Physiol Biophys. 32:179–187. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Danial NN: BAD: undertaker by night,
candyman by day. Oncogene. 27(Suppl 1): S53–S70. 2008. View Article : Google Scholar
|
|
24
|
Levine B, Sinha S and Kroemer G: Bcl-2
family members: dual regulators of apoptosis and autophagy.
Autophagy. 4:600–606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stauffer SR: Small molecule inhibition of
the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of
an in vivo chemopotentiator ABT-737. Curr Top Med Chem. 7:961–965.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hojabrpour P, Waissbluth I, Ghaffari M,
Cox ME and Duronio V: CaMKII-gamma mediates phosphorylation of BAD
at Ser170 to regulate cytokine-dependent survival and
proliferation. Biochem J. 442:139–149. 2012. View Article : Google Scholar
|
|
27
|
Yin DL, Jiang HC, Liang YJ, Meng XZ, Wang
JB, Zheng TS and Liu LX: Precise hepatectomy guided by minimally
invasive surgery: a novel strategy for liver resection.
Hepatogastroenterology. 59:1951–1959. 2012.PubMed/NCBI
|
